A detailed history of Operose Advisors LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Operose Advisors LLC holds 4,069 shares of ABT stock, worth $466,958. This represents 0.15% of its overall portfolio holdings.

Number of Shares
4,069
Previous 4,069 -0.0%
Holding current value
$466,958
Previous $422,000 9.72%
% of portfolio
0.15%
Previous 0.15%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$109.52 - $120.96 $401,938 - $443,923
3,670 Added 919.8%
4,069 $462,000
Q4 2023

Feb 12, 2024

SELL
$90.19 - $110.4 $45,095 - $55,200
-500 Reduced 55.62%
399 $43,000
Q3 2023

Nov 13, 2023

BUY
$95.53 - $114.62 $85,881 - $103,043
899 New
899 $87,000
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $3,676 - $4,257
-38 Reduced 15.2%
212 $21,000
Q4 2021

Feb 14, 2022

BUY
$115.53 - $141.46 $28,882 - $35,365
250 New
250 $35,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Operose Advisors LLC Portfolio

Follow Operose Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Operose Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Operose Advisors LLC with notifications on news.